Evelo Biosciences, Inc. ( EVLO) - Stock Earnings
EVLO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 17, 2026, midnight | — / — | — | — / — | — |
EVLO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -25.3 million USD | 0 USD |
| 2023Q2 | -21.1 million USD | — USD |
| 2023Q3 | -12.4 million USD | — USD |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
EVLO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -122.2 million USD | 0 USD |
| 2022 | -114.5 million USD | 0 USD |
| 2023 | -82.3 million USD | — USD |
| 2026 Est. | — | — |
EVLO
Price: $0
52 week price:
Earnings Per Share: -19.55 USD
P/E Ratio: -1.81
Exchange: OEM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 71715
Market Capitalization: 1898